At PsychoGenics, we are dedicated to pushing the boundaries of scientific research and drug development in various therapeutic areas within the overall preclinical central nervous system (CNS) research field.
With our comprehensive capabilities and collaborative approach, we strive to make a significant impact in the following areas:
Your Partner in Preclinical CNS Studies: Advancing Neurological and Mental Health Research
With our portfolio of rodent disease models, extensive behavioral assays, bespoke study design, pioneering technology, and comprehensive expertise, PsychoGenics is a trusted partner for academia, biopharmaceutical companies, disease research foundations, and research institutions. Together, we can drive meaningful advancements in neurological and mental health research to improve the lives of patients worldwide.